dapagliflozin10mg30tab eva

Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. By preventing the kidneys from reabsorbing glucose back into the bloodstream, it promotes the excretion of excess sugar through urine. Beyond its glucose-lowering effects, it is also indicated for reducing the risk of hospitalization for heart failure in adults with heart failure and for reducing the risk of worsening kidney function in patients with chronic kidney disease.